Ovarian cancer stem cells: Elusive targets for chemotherapy

Research output: Contribution to journalReview article

11 Citations (Scopus)

Abstract

Ovarian cancer is one of the major causes of death in women with gynecologic malignancy. Most patients respond favorably to platinum therapy, but relapses are common. There is emerging evidence that a special subset of cells that is highly tumorigenic is responsible for recurrence of the disease. This subset of cells has been characterized by several groups and has been found to have the properties of cancer stem cells. They have been isolated from tumor samples obtained during surgical cytoreduction and also from the ascitic fluid of ovarian cancer patients. Currently, there are no known unique markers to define these cells, but several groups have used different approaches to purify them. Although some heterogeneity has been observed in these cells, most of them satisfy the functional definition of a stem cell. Advances in characterization of ovarian cancer stem cells are instrumental in developing therapies that specifically target them. This review describes the advances made in characterization of these cells, basis of their resistance to conventional chemotherapeutic agents and the prognostic implications of utilizing mechanisms specific to ovarian cancer stem cell for therapeutic interventions. Eliminating ovarian cancer stem cells could possibly lead to a prolongation of the disease-free survival period and hopefully a definitive cure.

Original languageEnglish (US)
Pages (from-to)3400-3408
Number of pages9
JournalMedical Oncology
Volume29
Issue number5
DOIs
StatePublished - Dec 1 2012
Externally publishedYes

Fingerprint

Neoplastic Stem Cells
Ovarian Neoplasms
Drug Therapy
Recurrence
Ascitic Fluid
Platinum
Disease-Free Survival
Cause of Death
Neoplasms
Stem Cells
Therapeutics

Keywords

  • Cancer stem cells
  • Chemotherapy
  • Ovarian cancer
  • Side population
  • Target

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Ovarian cancer stem cells : Elusive targets for chemotherapy. / Guddati, Achuta Kumar.

In: Medical Oncology, Vol. 29, No. 5, 01.12.2012, p. 3400-3408.

Research output: Contribution to journalReview article

@article{91435ade6863460f8ead0439bb742388,
title = "Ovarian cancer stem cells: Elusive targets for chemotherapy",
abstract = "Ovarian cancer is one of the major causes of death in women with gynecologic malignancy. Most patients respond favorably to platinum therapy, but relapses are common. There is emerging evidence that a special subset of cells that is highly tumorigenic is responsible for recurrence of the disease. This subset of cells has been characterized by several groups and has been found to have the properties of cancer stem cells. They have been isolated from tumor samples obtained during surgical cytoreduction and also from the ascitic fluid of ovarian cancer patients. Currently, there are no known unique markers to define these cells, but several groups have used different approaches to purify them. Although some heterogeneity has been observed in these cells, most of them satisfy the functional definition of a stem cell. Advances in characterization of ovarian cancer stem cells are instrumental in developing therapies that specifically target them. This review describes the advances made in characterization of these cells, basis of their resistance to conventional chemotherapeutic agents and the prognostic implications of utilizing mechanisms specific to ovarian cancer stem cell for therapeutic interventions. Eliminating ovarian cancer stem cells could possibly lead to a prolongation of the disease-free survival period and hopefully a definitive cure.",
keywords = "Cancer stem cells, Chemotherapy, Ovarian cancer, Side population, Target",
author = "Guddati, {Achuta Kumar}",
year = "2012",
month = "12",
day = "1",
doi = "10.1007/s12032-012-0252-6",
language = "English (US)",
volume = "29",
pages = "3400--3408",
journal = "Medical Oncology",
issn = "1357-0560",
publisher = "Humana Press",
number = "5",

}

TY - JOUR

T1 - Ovarian cancer stem cells

T2 - Elusive targets for chemotherapy

AU - Guddati, Achuta Kumar

PY - 2012/12/1

Y1 - 2012/12/1

N2 - Ovarian cancer is one of the major causes of death in women with gynecologic malignancy. Most patients respond favorably to platinum therapy, but relapses are common. There is emerging evidence that a special subset of cells that is highly tumorigenic is responsible for recurrence of the disease. This subset of cells has been characterized by several groups and has been found to have the properties of cancer stem cells. They have been isolated from tumor samples obtained during surgical cytoreduction and also from the ascitic fluid of ovarian cancer patients. Currently, there are no known unique markers to define these cells, but several groups have used different approaches to purify them. Although some heterogeneity has been observed in these cells, most of them satisfy the functional definition of a stem cell. Advances in characterization of ovarian cancer stem cells are instrumental in developing therapies that specifically target them. This review describes the advances made in characterization of these cells, basis of their resistance to conventional chemotherapeutic agents and the prognostic implications of utilizing mechanisms specific to ovarian cancer stem cell for therapeutic interventions. Eliminating ovarian cancer stem cells could possibly lead to a prolongation of the disease-free survival period and hopefully a definitive cure.

AB - Ovarian cancer is one of the major causes of death in women with gynecologic malignancy. Most patients respond favorably to platinum therapy, but relapses are common. There is emerging evidence that a special subset of cells that is highly tumorigenic is responsible for recurrence of the disease. This subset of cells has been characterized by several groups and has been found to have the properties of cancer stem cells. They have been isolated from tumor samples obtained during surgical cytoreduction and also from the ascitic fluid of ovarian cancer patients. Currently, there are no known unique markers to define these cells, but several groups have used different approaches to purify them. Although some heterogeneity has been observed in these cells, most of them satisfy the functional definition of a stem cell. Advances in characterization of ovarian cancer stem cells are instrumental in developing therapies that specifically target them. This review describes the advances made in characterization of these cells, basis of their resistance to conventional chemotherapeutic agents and the prognostic implications of utilizing mechanisms specific to ovarian cancer stem cell for therapeutic interventions. Eliminating ovarian cancer stem cells could possibly lead to a prolongation of the disease-free survival period and hopefully a definitive cure.

KW - Cancer stem cells

KW - Chemotherapy

KW - Ovarian cancer

KW - Side population

KW - Target

UR - http://www.scopus.com/inward/record.url?scp=84880322222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880322222&partnerID=8YFLogxK

U2 - 10.1007/s12032-012-0252-6

DO - 10.1007/s12032-012-0252-6

M3 - Review article

C2 - 22638913

AN - SCOPUS:84880322222

VL - 29

SP - 3400

EP - 3408

JO - Medical Oncology

JF - Medical Oncology

SN - 1357-0560

IS - 5

ER -